TY - JOUR
T1 - Comparative Evaluation of Plasma Metabolomic Data from Multiple Laboratories
AU - Nishiumi, Shin
AU - Izumi, Yoshihiro
AU - Hirayama, Akiyoshi
AU - Takahashi, Masatomo
AU - Nakao, Motonao
AU - Hata, Kosuke
AU - Saigusa, Daisuke
AU - Hishinuma, Eiji
AU - Matsukawa, Naomi
AU - Tokuoka, Suzumi M.
AU - Kita, Yoshihiro
AU - Hamano, Fumie
AU - Okahashi, Nobuyuki
AU - Ikeda, Kazutaka
AU - Nakanishi, Hiroki
AU - Saito, Kosuke
AU - Hirai, Masami Yokota
AU - Yoshida, Masaru
AU - Oda, Yoshiya
AU - Matsuda, Fumio
AU - Bamba, Takeshi
N1 - Funding Information:
Funding: This research was funded in part by the Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (21K12676 for S.N.), by the AMED-CREST from the Japan Agency for Medical Research and Development (AMED) (19gm0710013h0506 for S.N.), by the Practical Research Project for Rare/Intractable Disease from the AMED (20ek0109396S0403 for S.N.), by the JST Moonshot from the Japan Science and Technology Agency (JST) (JPMJMS2011-62 for Y.I.), by the JST-Mirai Program from the JST (JPMJMI20G1 for Y.I.), by the Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP) from the JST (JPMJTR204J for T.B.), by the AMED-CREST from the AMED (JP21gm0910010 and JP21gm1010010 for T.B.) by the Advanced Genome Research and Bioinformatics Study to Facilitate Medical Innovation (GRIFIN) from the AMED (20km0405209h0003 for A.H.), by the Grant-in-Aid for Scientific Research on Innovative Areas (17H06303 for F.M.), by the Tohoku Medical Megabank Project from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (D.S., E.H., N.M.), by the Tohoku Medical Megabank Project from the AMED (JP20km0105001 and JP20km0105002 for D.S., E.H., N.M.], by the Project for Promoting Public Utilization of Advanced Research Infrastructure from the MEXT (D.S., E.H., N.M.), and by the Sharing and administrative network for research equipment from the MEXT (D.S., E.H., N.M.).
Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2022/2
Y1 - 2022/2
N2 - In mass spectrometry-based metabolomics, the differences in the analytical results from different laboratories/machines are an issue to be considered because various types of machines are used in each laboratory. Moreover, the analytical methods are unique to each laboratory. It is important to understand the reality of inter-laboratory differences in metabolomics. Therefore, we have evaluated whether the differences in analytical methods, with the exception sample pretreatment and including metabolite extraction, are involved in the inter-laboratory differences or not. In this study, nine facilities are evaluated for inter-laboratory comparisons of metabolomic analysis. Identical dried samples prepared from human and mouse plasma are distributed to each laboratory, and the metabolites are measured without the pretreatment that is unique to each laboratory. In these measurements, hydrophilic and hydrophobic metabolites are analyzed using 11 and 7 analytical methods, respectively. The metabolomic data acquired at each laboratory are integrated, and the differences in the metabolomic data from the laboratories are evaluated. No substantial difference in the relative quantitative data (human/mouse) for a little less than 50% of the detected metabolites is observed, and the hydrophilic metabolites have fewer differences between the laboratories compared with hydrophobic metabolites. From evaluating selected quantitatively guaranteed metabolites, the proportion of metabolites without the inter-laboratory differences is observed to be slightly high. It is difficult to resolve the inter-laboratory differences in metabolomics because all laboratories cannot prepare the same analytical environments. However, the results from this study indicate that the inter-laboratory differences in metabolomic data are due to measurement and data analysis rather than sample preparation, which will facilitate the understanding of the problems in metabolomics studies involving multiple laboratories.
AB - In mass spectrometry-based metabolomics, the differences in the analytical results from different laboratories/machines are an issue to be considered because various types of machines are used in each laboratory. Moreover, the analytical methods are unique to each laboratory. It is important to understand the reality of inter-laboratory differences in metabolomics. Therefore, we have evaluated whether the differences in analytical methods, with the exception sample pretreatment and including metabolite extraction, are involved in the inter-laboratory differences or not. In this study, nine facilities are evaluated for inter-laboratory comparisons of metabolomic analysis. Identical dried samples prepared from human and mouse plasma are distributed to each laboratory, and the metabolites are measured without the pretreatment that is unique to each laboratory. In these measurements, hydrophilic and hydrophobic metabolites are analyzed using 11 and 7 analytical methods, respectively. The metabolomic data acquired at each laboratory are integrated, and the differences in the metabolomic data from the laboratories are evaluated. No substantial difference in the relative quantitative data (human/mouse) for a little less than 50% of the detected metabolites is observed, and the hydrophilic metabolites have fewer differences between the laboratories compared with hydrophobic metabolites. From evaluating selected quantitatively guaranteed metabolites, the proportion of metabolites without the inter-laboratory differences is observed to be slightly high. It is difficult to resolve the inter-laboratory differences in metabolomics because all laboratories cannot prepare the same analytical environments. However, the results from this study indicate that the inter-laboratory differences in metabolomic data are due to measurement and data analysis rather than sample preparation, which will facilitate the understanding of the problems in metabolomics studies involving multiple laboratories.
KW - Hydrophilic metabolite
KW - Hydrophobic metabolite
KW - Inter-laboratory comparison
KW - Mass spectrometry
KW - Metabolomics
KW - Relative quantification
UR - http://www.scopus.com/inward/record.url?scp=85124152796&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85124152796&partnerID=8YFLogxK
U2 - 10.3390/metabo12020135
DO - 10.3390/metabo12020135
M3 - Article
AN - SCOPUS:85124152796
SN - 2218-1989
VL - 12
JO - Metabolites
JF - Metabolites
IS - 2
M1 - 135
ER -